home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops  

Powders: Their Properties and Processing

  June 07, 2011  
CfPA - The Center for Professional Advancement, Amsterdam, The Netherlands
3-5 October 2011

Who Should Attend
The course is designed primarily for those concerned with products developed or manufactured from powdered solids in the pharmaceutical, cosmetic and related industries. Most of the material, however, will be general enough to prove valuable to a much wider range of interests including, but not limited to:

  • Scientists
  • Suppliers
  • Technologists

The primary purpose of this course is to review the various properties of powdered solids pertinent to the development and manufacture of the products of the pharmaceutical, cosmetic and allied industries. In particular, the latest experimental techniques and equipment for evaluating important properties of powders will be discussed and related to both the underlying principles and common industrial problems. The different powder processing operations will be discussed and the range of equipment and machinery for each will be critically reviewed.

Each topic will be briefly introduced at a fairly fundamental level, but will then be extended to cover more sophisticated and innovative techniques, emphasizing the practical usefulness whenever relevant. The formal sessions will be supplemented by informal discussion periods. You will be encouraged to raise specific problems.

Organized by: CfPA - The Center for Professional Advancement
Invited Speakers: Dr. Cecil W. Propst; Director R&D, SPI Pharma Group, Grand Haven

Dr. Cecil W. Propst is Director of R&D for SPI Pharma Group, Grand Haven, a processor of a variety of specialty ingredients for the food, drug, cosmetic and related industries. He was Director of Quality Assurance and Technical Development at Fleming and Company and, before that, President of Manufacturing Chemists. His duties included system design, product and process development, and regulatory affairs. Previously, he served as cGMP Facilities Director for the University of Maryland at Baltimore, in connection with the University’s contract with the FDA.

Dr. Propst also served as Director of Technical Development for Stellar Manufacturing; Director of Quality Compliance for SmithKline Beecham; Director of Quality Assurance for Norcliff Thayer (a Revlon Company); and Group Leader/Product Development and Manager/Quality Control for Lewis Howe Company. He consults with TabTech for the chemical, diagnostic, food, engineering and beverage industries.
Deadline for Abstracts: n/a
Registration: Please click here for registration information.
E-mail: sberg@cfpa.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.